Truist Financial Corp Has $286,000 Stock Position in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Truist Financial Corp reduced its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 11.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,868 shares of the company’s stock after selling 2,482 shares during the quarter. Truist Financial Corp’s holdings in BlackRock Health Sciences Term Trust were worth $286,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of BMEZ. Brown Brothers Harriman & Co. acquired a new position in BlackRock Health Sciences Term Trust in the third quarter worth about $32,000. K2 Principal Fund L.P. acquired a new stake in BlackRock Health Sciences Term Trust during the third quarter valued at approximately $158,000. Jane Street Group LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 3rd quarter valued at approximately $357,000. Kingswood Wealth Advisors LLC acquired a new position in shares of BlackRock Health Sciences Term Trust in the 4th quarter worth approximately $420,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of BlackRock Health Sciences Term Trust during the 4th quarter worth approximately $471,000.

BlackRock Health Sciences Term Trust Stock Up 1.6 %

Shares of BMEZ stock opened at $15.69 on Thursday. The stock’s fifty day simple moving average is $15.70 and its 200 day simple moving average is $15.67. BlackRock Health Sciences Term Trust has a one year low of $14.27 and a one year high of $16.75.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be paid a $0.1763 dividend. The ex-dividend date is Friday, March 14th. This represents a $2.12 annualized dividend and a dividend yield of 13.48%.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.